期刊文献+

氯胺酮对人肺癌A549细胞生长的影响及相关机制研究 被引量:1

The effect and mechanism of ketamine on proliferation of human lung adenocarcinoma A549 cells
下载PDF
导出
摘要 目的 :探讨麻醉类药物氯胺酮和吗啡对人肺癌A549细胞生长的影响及相关作用机制。方法:体外培养肺癌细胞系A549,细胞培养24 h后,随机分为3组:对照组(NC组,加0.9%Na Cl处理)、氯胺酮组(K1、K2、K3组,分别加氯胺酮100、200、400μg/m L处理)和吗啡组(M1、M2、M3组,分别加吗啡25、50、100μg/m L处理)。持续作用24 h后,Transwell小室培养体系测定肿瘤细胞的迁移率;双荧光素酶报告基因法测定NF-κB转录活性;48 h后MTT法测定细胞增殖抑制率;Western blot技术测定NF-κB P65的蛋白表达;QPCR技术检测细胞内IL-1β和COX-2的m RNA表达。结果:1与NC组比较,M1、M2组表现为促进A549细胞迁移(P<0.05),M3组作用不明显;K1、K2、K3组表现为抑制A549细胞迁移(P<0.05);2与NC组比较,M1、M2组表现为促进A549细胞增殖(P<0.05),M3组作用不明显;K2、K3组表现为抑制A549细胞增殖(P<0.05),K1组不明显;3与NC组比较,M1、M2、M3组表现为促进IL-1β、COX-2的m RNA表达(P<0.05);K2、K3组表现为抑制IL-1β、COX-2的m RNA表达(P<0.05),K1组不明显;4与NC组比较,M1、M2、M3组表现为促进P65的转录和蛋白表达(P<0.05),K1、K2、K3组表现为抑制P65的转录和蛋白表达(P<0.05)。结论:与阿片类药物不同,氯胺酮通过NF-κB信号通路及其下游因子IL-1β和COX-2抑制人肺腺癌细胞A549的迁移和增殖,可能更适用于肺癌患者的术后镇痛。 Objective:To investigate the effect and mechanism of anesthetic ketamine and morphine on the proliferation of cultured human lung adenocarcinoma A549 cell. Methods:Human lung adenocarcinoma A549 cells were treated with different concentration of ketamine(K1,K2,K3 is 100,200,and 400 μg / m L,respectively)and morphine(M1,M2,M3 is 25,50 and 100 μg / m L,respectively)for24 and 48 h. After cultured for 24 h,the effect of ketamine and morphine on the invasive ability of A549 cells were measured by transwell invasion. NF-κB transcription activity were determined by luciferase assay. After cultured for 48 h,the proliferation inhibition rates of A549 cells were assessed by methyl thiazolyl tetrazolium(MTT) assay. Protein expressions of NF-κB P65 were determined by Western blot. IL-1β and COX-2 expression were determined by QPCR. Results:(1)Compared with the control group,M1 and M2 enhanced A549 cell proliferation and migration(P 〈0.05),while K1,K2 and K3 suppressed A549 cells migration(P 〈0.05).(2)M1,M2 and M3 enhanced IL-1β and COX-2 expression(P〈 0.05),but K2 and K3 had opposing effects(P 〈0.05). M1,M2,and M3 enhanced NF-κB and P65 transcription activity and protein expressions(P 〈0.05),while K1,K2 and K3 had opposing effects(P 〈0.05). Conclusion:Unlike opioids,ketamine inhibits the proliferation and migration of A549 through NF-κB and its down stream factor IL-1β and COX-2,may be more suitable for lung cancer patients postoperative analgesia.
出处 《南京医科大学学报(自然科学版)》 CAS CSCD 北大核心 2015年第10期1387-1392,共6页 Journal of Nanjing Medical University(Natural Sciences)
基金 南通市市级科技计划(指导性 HS13928)
关键词 A549细胞 氯胺酮 吗啡 NF-ΚB A549 ketamine morphine NF-κB
  • 相关文献

参考文献26

  • 1Gottschalk A, Sharma S, Ford J, et al. Review article : the role of the perioperative period in recurrence after cancer surgery[J]. Anesth Analg,2010,110(6) : 1636-1643.
  • 2Sessler DI. Long term consequences of anesthetic man-agement [ J ]. Anesthesiology, 2009,111 ( 1 ) : 1-4.
  • 3Vallejo R, de Leon-Casasola O, Benyamin R. Opioid ther- apy and immunosuppression:a revie[J] 2004,11(5) :354-365.
  • 4Am J Therap, Roy S, Balasubramanian S, Sumandeep S, et al. Morphine directs T cells toward T(H2)differentiation[J]. Surgery, 2001,130(2) :304-309.
  • 5Mathew B, Lennon FE,Siegler J,et al. The novel role of the mu opioid receptor in lung cancer progression:a lab- oratory investigation [J]. Anesth Analg,2011,112 (3) : 558-567.
  • 6Singleton PA,Moss J. Effect of perioperative opioids on cancer recurrence: a hypothesis [J]. Future Oncol, 2010,6 (8) : 1237-1242.
  • 7Ryu HG,Lee CJ,Kim YT,et al. Preemptive Low-dose epidural ketamine for preventing chronic postthoracotomy pain: A prospective, double-blinded, randomized, clinical trial [ J ]. Clin J Pain, 2011,27 (4) : 304-308.
  • 8Chazan S,Buda I,Nesher N,et al. Low-dose ketamine via intravenous patient-controlled analgesia device after vaious transthoracic procedures improves analgesia and patient and family satisfaction[J]. Pain Manag Nurs, 2010,11(3) : 169-176.
  • 9Nesher N, Ekstein MP, Paz Y, et al. Morphine with adju- vant ketamine vs higher dose of morphine alone for im- mediate postthoracotomy analgesia [J]. Chest,2009, 136 ( 1 ) : 245-252.
  • 10Jackson K,Ashby M,Howell D,et al. The effectiveness and adverse effects profile of "burst" ketamine in refrac- tory cancer pain:The VCOG PM 1-00 study[J]. J Pallia- tive Care,2010,26(3) : 176-183.

同被引文献5

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部